• TRENTAL 400mg Sustained Release (SR) Tablets are used as a treatment for peripheral vascular diseases.
• Active ingredient: Pentoxifylline 400mg.
• Indication: Trental is a hemorrheologic agent, i.e., an agent that affects blood viscosity. It is used to improve blood flow in patients with chronic peripheral arterial disease, such as intermittent claudication or trophic ulcers. Improved blood flow helps reduce leg cramps and other symptoms of vascular disease.
• Dose: One SR tablets (400 mg) three times a day with meals. It is recommended treatment is continued for at least 8 weeks.
• Sustained release tablets must be swallowed whole.